An official website of the United States government
CRISPR-Cas9 is revolutionizing how we conduct scientific research, treat disease, and develop new crops. The widespread impact of this genome-editing technology makes it critical for undergraduate students to understand and engage with this new tool. In this article, we describe a multi-week lab module that teaches undergraduates how to design CRISPR-Cas9 constructs and screen for CRISPR-modified genotypes. The module is conducted through the lens of independent research; students conduct a genotype screen for novel knockout mutations. In our module, students screen Zea mays (maize) seedlings for mutations in the MAD2 gene, which assists our ongoing investigation of meiotic chromosome segregation. This module can be adapted to knockout any gene in any organism, and thus align with an instructor’s research program. Engaging in original research helps undergraduate students develop independence and initiative in the lab as well as the molecular techniques of CRISPR-Cas9.
more »
« less
Knockout of a secondary alcohol dehydrogenase gene in Nocardia cholesterolicum NRRL 5767 by CRISPR-Cas9 technology
In literature, Nocardia cholesterolicum NRRL 5767 (NC NRRL5767) is well-known for its ability to transform ~95% of added oleic acid, an abundant agricultural commodity, to value-added product of 10-hydroxystearic acid (10-HSA). A small amount of unwanted 10-ketostearic acid (10-KSA) was also produced. This microbe also transforms ~80% of added linoleic acid to 10-hydroxy-12(Z)-octadecenoic acid (10-OH-12-OD) (an isomer of ricinoleic acid) with minor 10-oxo-12(Z)-octadecenoic acid (10-oxo-12-OD). The conversion of oleic acid to 10-HSA and then to 10-KSA (or linoleic acid to 10-OH-12-OD and then to 10-oxo-12-OD) is catalyzed by oleate hydratase and secondary alcohol dehydrogenase (2o-ADH), respectively. The objective of this project was to knockout the 2o-ADH gene in NC NRRL5767 so that the sole biotransformation product from oleic acid would be 10-HSA. Here, we report construction of CRISPR/Cas9/sgRNA chimeric plasmid that specifically target 5’ coding region of the 2o-ADH gene by Golden Gate Assembly. The construct was confirmed by DNA sequencing and transformed into NC NRRL 5767 via electroporation. The transformants were selected by apramycin resistance and screened for the presence of the target insert (crRNA) by PCR. The ability of the selected transformants to transform oleic acid to 10-HSA was screened by TLC and further confirmed by GC-MS. Our results showed that two of the transformants produced only 10-HSA with no detectable 10-KSA from oleic acid suggesting successful knockout of the 2o-ADH gene. Final confirmation came from the isolation of genomic DNA from these two transformants and the wild type NC NRRL5767 (used as DNA template) and using 17 primers (locate at different positions along the 2o-ADH gene and the 5’ upstream of this gene) for PCR. To our best knowledge, this is the first report to knockout the target gene in Nocardia species by CRISPR-Cas9 technology.
more »
« less
- Award ID(s):
- 1827209
- PAR ID:
- 10174163
- Date Published:
- Journal Name:
- 2019 ACS Midwest Regional Meeting
- Format(s):
- Medium: X
- Sponsoring Org:
- National Science Foundation
More Like this
-
-
Abstract Fibro-adipogenic progenitor cells (FAPs) are muscle resident stem cells that contribute to marbling- a key determinant of beef quality grade. FAPs retain their stemness into the pre-weaning period in cattle, creating opportunities for early-life interventions to promote marbling. Lipids are a critical dietary component for calves, yet there is limited information on how different dietary fatty acids influence FAPs. The objective of this experiment was to evaluate the effect of fatty acids on FAP proliferation and adipogenic differentiation in vitro. An immortalized FAP cell line was used for the initial fatty acid screen and primary bovine FAPs (N=2 cattle) for subsequent experiments. Fatty acids were supplemented as BSA conjugates in culture media between 25-200µM. Control treatments included a vehicle control (BSA) in both experiments, and a no treatment control (growth media) and metabolic control (elaidic acid) in primary cell experiments. To assess proliferation, 10µM EdU was added into the media after cell pre-treatment with fatty acids and incubated for 24 hours (immortalized cells) or 6 hours (primary cells). To assess adipogenesis, FAPs were cultured with treatments in differentiation media for 3 days then maturation media for 7 days. Lipid droplets were assessed via Oil Red O in brightfield and fluorescent microscopy; EdU, nuclei, and PPARγ intensity were assessed via immunofluorescence. Image analysis was conducted in ImageJ, and data analysis was conducted in RStudio. An immortalized FAP line was used for an initial screen of oleic, palmitic, stearic, lauric, and linoleic acid at 25, 62.5, 100, 150, and 200µM. We found significant interaction effects between fatty acid and concentration for proliferation rates (p=0.0021) and the number of lipid droplets per cell (p=0.0016), while the median lipid droplet size was only impacted by fatty acid treatment (p< 0.0001). Notably, increasing stearic acid decreased proliferation, oleic and linoleic increased lipid droplet size, and oleic, palmitic, and stearic increased lipid droplets per cell. From these results, 150µM linoleic and oleic acid were selected for further testing using primary bovine FAPs. Treatments had no significant impact on bovine FAP proliferation or PPARγ expression. In adipogenic differentiation, the addition of any fatty acid supported over 190% more lipid droplets per cell (p< 0.05) and a 225% larger median lipid droplet size (p< 0.01) compared to the vehicle control. Oleic acid increased median lipid droplet size compared to linoleic acid (p=0.0429). Overall, this preliminary work presents evidence that FAP lipid accumulation and proliferation can be differentially impacted by supplemental fatty acids. For calf nutrition, this work highlights the potential importance of dietary fat to target marbling development. For this application, further work should assess the cellular metabolism and mechanisms related to fatty acid supplementation on adipogenic differentiation of FAPs, and assess additional fatty acids.more » « less
-
Slotman, Michel (Ed.)Abstract The wide distribution of Culex (Cx.) pipiens complex mosquitoes makes it difficult to prevent the transmission of mosquito-borne diseases in humans. Gene editing using CRISPR/Cas9 is an effective technique with the potential to solve the growing problem of mosquito-borne diseases. This study uses the ReMOT Control technique in Culex pipiens pallens (L.) to produce genetically modified mosquitoes. A microinjection system was established by injecting 60 adult female mosquitoes—14 µl injection mixture was required, and no precipitation occurred with ≤1 µl of endosomal release reagents (chloroquine or saponin). The efficiency of delivery of the P2C-enhanced green fluorescent protein-Cas9 (P2C-EGFP-Cas9) ribonucleoprotein complex into the ovary was 100% when injected at 24 h post-bloodmeal (the peak of vitellogenesis). Using this method for KMO knockout, we found that gene editing in the ovary could also occur when P2C-Cas9 RNP complex was injected into the hemolymph of adult Cx. pipiens pallens by ReMOT Control. In the chloroquine group, of the 2,251 G0 progeny screened, 9 individuals showed with white and mosaic eye phenotypes. In the saponin group, of the 2,462 G0 progeny screened, 8 mutant individuals were observed. Sequencing results showed 13 bp deletions, further confirming the fact that gene editing occurred. In conclusion, the successful application of ReMOT Control in Cx. pipiens pallens not only provides the basic parameters (injection parameters and injection time) for this method but also facilitates the study of mosquito biology and control.more » « less
-
Abstract High‐precision genome editing tools, such as programmable nucleases, are poised to transform crop breeding and significantly impact fundamental plant research. Among these tools, the CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats)/Cas9 (CRISPR‐associated 9) system is a programmable, RNA‐guided nuclease that introduces targeted, site‐specific double‐stranded breaks in the target DNA loci. When these breaks are repaired, it often results in a frame‐shift mutation via short insertion/deletion (indel), leading to gene knockout. Since its first successful use in plants, CRISPR/Cas9 has been widely adopted for targeting genes of agronomic and scientific importance in multiple crops, including rice, maize, wheat, and sorghum. These cereal crops ensure global food security, provide essential nutrition, and support economic stability. Additionally, such crops support biofuel production, livestock feed, and sustainable farming practices through crop rotation. This article outlines the strategies for implementing CRISPR/Cas9 genome editing in plants, including a step‐by‐step process of guide RNA target selection, oligonucleotide design, construct development, assembly, and analysis of genome edits. © 2025 The Author(s). Current Protocols published by Wiley Periodicals LLC. Basic Protocol 1: CRISPR/Cas9 guide RNA target selection Support Protocol 1: Genomic DNA extraction in‐house protocol Basic Protocol 2: Construction of a binary plasmid vector Support Protocol 2:Agrobacteriumtransformation with a binary vector construct and stability check Support Protocol 3: Plant transformation Basic Protocol 3: Genotyping of edited eventsmore » « less
-
There is currently no gene expression assay that can assess if premalignant lesions will develop into invasive breast cancer. This study sought to identify biomarkers for selecting patients with a high potential for developing invasive carcinoma in the breast with normal histology, benign lesions, or premalignant lesions. A set of 26-gene mRNA expression profiles were used to identify invasive ductal carcinomas from histologically normal tissue and benign lesions and to select those with a higher potential for future cancer development (ADHC) in the breast associated with atypical ductal hyperplasia (ADH). The expression-defined model achieved an overall accuracy of 94.05% (AUC = 0.96) in classifying invasive ductal carcinomas from histologically normal tissue and benign lesions (n = 185). This gene signature classified cancer development in ADH tissues with an overall accuracy of 100% (n = 8). The mRNA expression patterns of these 26 genes were validated using RT-PCR analyses of independent tissue samples (n = 77) and blood samples (n = 48). The protein expression of PBX2 and RAD52 assessed with immunohistochemistry were prognostic of breast cancer survival outcomes. This signature provided significant prognostic stratification in The Cancer Genome Atlas breast cancer patients (n = 1100), as well as basal-like and luminal A subtypes, and was associated with distinct immune infiltration and activities. The mRNA and protein expression of the 26 genes was associated with sensitivity or resistance to 18 NCCN-recommended drugs for treating breast cancer. Eleven genes had significant proliferative potential in CRISPR-Cas9/RNAi screening. Based on this gene expression signature, the VEGFR inhibitor ZM-306416 was discovered as a new drug for treating breast cancer.more » « less
- Free Publicly Accessible Full Text
-
Accepted Manuscript
- Conference Paper:
- The DOI is not currently available.
